Immatics N.V. (IMTX) stock
IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 1/30
$6.10−0.19 (-3.02%)
Close on Nov 18, 2026Market cap $817.84MP/E –Yield –
Immatics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Immatics's pe ratio was 62.5× on Feb 27, 2026, against 28.9× a year earlier. Over the last 2 years it ranged from 15.9× to 65.8×, with a median of 29.8×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Feb 27, 2026 | 62.5× | −1.4 |
| 2025 | Dec 31, 2025 | 63.9× | +35.0 |
| 2024 | Feb 29, 2024 | 28.9× | +5.1 |
| 2023 | Dec 29, 2023 | 23.8× | – |
See a number that looks wrong?